Primary, pulmonary providers endorse lung CA screening

October 12, 2017

(HealthDay)—Primary care clinicians and pulmonologists endorse lung cancer screening (LCS), but there are limitations in their knowledge of screening components, according to a study published online Sept. 21 in the Annals of the American Thoracic Society.

Matthew Triplette, M.D., M.P.H., from the University of Washington in Seattle, and colleagues conducted an electronic survey of primary care and pulmonary providers to examine knowledge, beliefs, attitudes, barriers, and facilitators related to LCS. There were 196 participants; 80 percent of them were primary care clinicians, 19 percent were pulmonologists, and 1 percent were others.

The researchers found that 74 percent of participants endorsed the effectiveness of LCS; performance was suboptimal on knowledge-based assessments of eligibility, documentation, and nodule management. Key barriers included inadequate time and staffing (both 36 percent), and not addressing screening because patients had too many other illnesses (38 percent). Decision aids, used at the point-of-referral, were important clinical facilitators of LCS (51 percent) and facilitators of provider knowledge (59 percent). Several differences were seen by provider specialty, including primary care clinicians more often reporting time constraints and their patients having too many other illnesses to address screening.

"Providers endorsed the benefits of LCS, but there are limitations in provider knowledge of key screening components," the authors write.

Explore further: EHR-based prompt ups hepatitis C screening for baby boomers

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

EHR-based prompt ups hepatitis C screening for baby boomers

July 20, 2017
(HealthDay)—Implementation of an electronic health record (EHR)-based prompt can improve hepatitis C virus (HCV) screening rates among baby boomers, according to a study published online July 17 in Hepatology.

Patient with CAS of 50 percent should not undergo screening

October 3, 2017
(HealthDay)—A vascular surgeon and primary care physician agree that an asymptomatic patient with cardiovascular risk and stenosis of 50 percent on screening carotid ultrasonography should not undergo carotid artery stenosis ...

Many pulmonologists under-, over-screen with LDCT

September 28, 2015
(HealthDay)—Almost half of pulmonologists have a propensity for over- or under-use of low-dose computed tomography (LDCT) screening for lung cancer, according to a study published online Sept. 14 in the Annals of the American ...

CRC screen up for older patients, those not in labor force

July 28, 2017
(HealthDay)—Factors associated with colorectal cancer (CRC) screening rates at U.S. community health centers include age and insurance status, but not patient-provider communication, according to a study published online ...

Age, life expectancy influence termination of PSA screening

April 26, 2012
(HealthDay) -- Most primary care providers consider both a man's age and life expectancy in deciding whether to discontinue prostate-specific antigen (PSA) screenings, but multiple factors are involved in this decision, according ...

Screening patients at high-risk for lung cancer more likely when prmary care provider is familiar with guidelines

October 30, 2014
Patients at high-risk for developing lung cancer are more likely to receive low-dose computed tomography (LDCT) screening when their primary care provider is familiar with guideline recommendations for LDCT screening for ...

Recommended for you

What can salad dressing tell us about cancer? Think oil and vinegar

September 20, 2018
Researchers led by St. Jude Children's Research Hospital scientists have identified another way the process that causes oil to form droplets in water may contribute to solid tumors, such as prostate and breast cancer. The ...

Novel biomarker found in ovarian cancer patients can predict response to therapy

September 20, 2018
Despite months of aggressive treatment involving surgery and chemotherapy, about 85 percent of women with high-grade wide-spread ovarian cancer will have a recurrence of their disease. This leads to further treatment, but ...

Testing fluorescent tracers used to help surgeons determine edges of breast cancer tumors

September 20, 2018
A team of researchers with members from institutions in The Netherlands and China has conducted a test of fluorescent tracers meant to aid surgeons performing tumor removal in breast cancer patients. In their paper published ...

Cancer immunotherapy might benefit from previously overlooked immune players

September 20, 2018
Cancer immunotherapy—efforts to boost a patient's own immune system, allowing it to better fight cancer cells on its own—has shown great promise for some previously intractable cancers. Yet immunotherapy doesn't work ...

New way to target advanced breast cancers

September 20, 2018
A cytokine signature found in certain kinds of breast cancer cells can not only serve as a diagnostic tool for HER2-negative cancers but also offer an effective treatment target.

Understanding epilepsy in pediatric tumors

September 20, 2018
Pediatric brain tumors are characterized by frequent complications due to intractable epilepsy compared to adult brain tumors. However, the genetic cause of refractory epilepsy in pediatric brain cancer has not been elucidated ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.